Authors:
RAYMOND E
BOIGE V
GATINEAU M
FRAZER S
LAROCHE C
LABBE S
PAUTIER P
DUCREUX M
ARMAND JP
Citation: E. Raymond et al., PHASE-I AND PHARMACOKINETIC STUDY OF DX-8951F, A NOVEL TOPOISOMERASE-1 INHIBITOR, USING A 30 MINUTE INFUSION EVERY 3 WEEKS, Annals of oncology, 9, 1998, pp. 248-248
Authors:
RIXE O
GATINEAU M
BATOUCHE M
RAYMOND E
DOMENGE C
JANOT F
SCHWAAB G
LUBOINSKI B
ARMAND JP
Citation: O. Rixe et al., SEQUENTIAL NEOADJUVANT CHEMOTHERAPY (SC) FOR HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC), Annals of oncology, 9, 1998, pp. 672-672
Authors:
FIZAZI K
COJEAN I
PIGNON JP
RIXE O
GATINEAU M
HADEF S
ARRIAGADA R
BALDEYROU P
COMOY E
LECHEVALIER T
Citation: K. Fizazi et al., NORMAL SERUM NEURON-SPECIFIC ENOLASE (NSE) VALUE AFTER THE FIRST CYCLE OF CHEMOTHERAPY - AN EARLY PREDICTOR OF COMPLETE RESPONSE AND SURVIVAL IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA, Cancer, 82(6), 1998, pp. 1049-1055
Authors:
GATINEAU M
RIXE O
REY A
TRANDAFIR L
LECHEVALIER T
Citation: M. Gatineau et al., PHASE I II STUDY OF THE ADDITION OF TIRAPAZAMINE (TIRA) TO CISPLATINE(CDDP)/NAVELBINE (NVB) IN PATIENTS WITH INOPERABLE NON-SMALL-CELL LUNG-CANCER (NSCLC)/, European journal of cancer, 33, 1997, pp. 1125-1125
Authors:
RIBRAG V
ELHAJJ M
NASR F
BAYLE C
LECHEVALIER T
LESCENE A
GATINEAU M
BENNACEURGRISCELLI A
Citation: V. Ribrag et al., RT-PCR DETECTION OF PGP-9.5 M-RNA IN BONE-MARROW BLOOD-SAMPLES IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA, Blood, 90(10), 1997, pp. 4341-4341
Authors:
SIMILOWSKI T
GATINEAU M
STRAUS C
DERENNE JP
Citation: T. Similowski et al., IATROGENIC DISORDERS IN THE ACTIVE RESPIR ATORY SYSTEM - VENTILATORY CONTROL AND ITS EFFECTORS, Revue des maladies respiratoires, 13(4), 1996, pp. 361-379
Authors:
LECUIT M
CAUMES E
BRICAIRE F
GATINEAU M
MENEGAUX F
GENTILINI M
Citation: M. Lecuit et al., ACUTE SUPPURATIVE SALMONELLA-ENTERITIDIS THYROIDITIS ASSOCIATED WITH THYROTOXICOSIS IN A PATIENT INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 20(1), 1995, pp. 196-196